Andrea Pilotto1,2, Francesca Schiano di Cola3, Enrico Premi3,4, Roberto Grasso3, Rosanna Turrone3, Stefano Gipponi3, Andrea Scalvini3, Elisabetta Cottini3, Barbara Paghera5, Valentina Garibotto6, Maria Cristina Rizzetti7, Laura Bonanni8, Barbara Borroni3, Silvia Morbelli9,10, Flavio Nobili10,11, Ugo Paolo Guerra12, Daniela Perani13, Alessandro Padovani3. 1. Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, P.zzale Spedali Civili, 1, 25123, Brescia, Italy. pilottoandreae@gmail.com. 2. Parkinson's Disease Rehabilitation Centre, FERB ONLUS - S. Isidoro Hospital, Trescore Balneario, BG, Italy. pilottoandreae@gmail.com. 3. Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, P.zzale Spedali Civili, 1, 25123, Brescia, Italy. 4. Stroke Unit, Azienda Socio Sanitaria Territoriale Spedali Civili, Spedali Civili Hospital, Brescia, Italy. 5. Nuclear Medicine Unit, University of Brescia, Brescia, Italy. 6. Department of Medical Imaging, Geneva University Hospital, Geneva, Switzerland. 7. Parkinson's Disease Rehabilitation Centre, FERB ONLUS - S. Isidoro Hospital, Trescore Balneario, BG, Italy. 8. Department of Neuroscience Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy. 9. Nuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy. 10. IRCCS ospedale Policlinico San Martino, Genoa, Italy. 11. Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy. 12. Nuclear Medicine Unit, Poliambulanza Hospital, Brescia, Italy. 13. Nuclear Medicine Unit San Raffaele Hospital, Division of Neuroscience San Raffaele Scientific Institute, Milan, Italy.
Abstract
PURPOSE: The aim of the study was to evaluate extrastriatal dopaminergic and serotonergic pathways in patients with Parkinson's disease (PD) and dementia with Lewy bodies (DLB) using 123I-FP-CIT SPECT imaging. METHODS: The study groups comprised 56 PD patients without dementia, 41 DLB patients and 54 controls. Each patient underwent a standardized neurological examination and 123I-FP-CIT SPECT. Binding in nigrostriatal and extrastriatal regions of interest was calculated in each patient from spatially normalized images. The occipital-adjusted specific to nondisplaceable binding ratio (SBR) in the different regions was compared among the PD patients, DLB patients and controls adjusting for the effects of age, sex, disease duration and serotonergic/dopaminergic treatment. Covariance analysis was used to determine the correlates of local and long-distance regions with extrastriatal 123I-FP-CIT deficits. RESULTS: Both PD and DLB patients showed lower 123I-FP-CIT SPECT SBR in several regions beyond the nigrostriatal system, especially the insula, cingulate and thalamus. DLB patients showed significantly lower 123I-FP-CIT SBR in the thalamus than controls and PD patients. Thalamic and cingulate 123I-FP-CIT SBR deficits were correlated, respectively, with limbic serotonergic and widespread cortical monoaminergic projections only in DLB patients but exhibited only local correlations in PD patients and controls. CONCLUSION: PD and DLB patients both showed insular dopamine deficits, whereas impairment of thalamic serotonergic pathways was specifically associated with DLB. Longitudinal studies are necessary to determine the clinical value of the assessment of extrastriatal 123I-FP-CIT SPECT.
PURPOSE: The aim of the study was to evaluate extrastriatal dopaminergic and serotonergic pathways in patients with Parkinson's disease (PD) and dementia with Lewy bodies (DLB) using 123I-FP-CIT SPECT imaging. METHODS: The study groups comprised 56 PDpatients without dementia, 41 DLB patients and 54 controls. Each patient underwent a standardized neurological examination and 123I-FP-CIT SPECT. Binding in nigrostriatal and extrastriatal regions of interest was calculated in each patient from spatially normalized images. The occipital-adjusted specific to nondisplaceable binding ratio (SBR) in the different regions was compared among the PDpatients, DLB patients and controls adjusting for the effects of age, sex, disease duration and serotonergic/dopaminergic treatment. Covariance analysis was used to determine the correlates of local and long-distance regions with extrastriatal 123I-FP-CIT deficits. RESULTS: Both PD and DLB patients showed lower 123I-FP-CIT SPECT SBR in several regions beyond the nigrostriatal system, especially the insula, cingulate and thalamus. DLB patients showed significantly lower 123I-FP-CIT SBR in the thalamus than controls and PDpatients. Thalamic and cingulate 123I-FP-CIT SBR deficits were correlated, respectively, with limbic serotonergic and widespread cortical monoaminergic projections only in DLB patients but exhibited only local correlations in PDpatients and controls. CONCLUSION:PD and DLB patients both showed insular dopamine deficits, whereas impairment of thalamic serotonergic pathways was specifically associated with DLB. Longitudinal studies are necessary to determine the clinical value of the assessment of extrastriatal 123I-FP-CIT SPECT.
Authors: J L Lancaster; M G Woldorff; L M Parsons; M Liotti; C S Freitas; L Rainey; P V Kochunov; D Nickerson; S A Mikiten; P T Fox Journal: Hum Brain Mapp Date: 2000-07 Impact factor: 5.038
Authors: Sean J Colloby; John T O'Brien; John D Fenwick; Michael J Firbank; David J Burn; Ian G McKeith; E David Williams Journal: Neuroimage Date: 2004-11 Impact factor: 6.556
Authors: Jan Booij; Jan de Jong; Kora de Bruin; Remco Knol; Maartje M L de Win; Berthe L F van Eck-Smit Journal: J Nucl Med Date: 2007-03 Impact factor: 10.057
Authors: Z Walker; D C Costa; R W H Walker; L Lee; G Livingston; E Jaros; R Perry; I McKeith; C L E Katona Journal: Neurology Date: 2004-05-11 Impact factor: 9.910
Authors: I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada Journal: Neurology Date: 2005-10-19 Impact factor: 9.910
Authors: Murat Emre; Dag Aarsland; Richard Brown; David J Burn; Charles Duyckaerts; Yoshikino Mizuno; Gerald Anthony Broe; Jeffrey Cummings; Dennis W Dickson; Serge Gauthier; Jennifer Goldman; Christopher Goetz; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Ian McKeith; Warren Olanow; Werner Poewe; Niall Quinn; Christina Sampaio; Eduardo Tolosa; Bruno Dubois Journal: Mov Disord Date: 2007-09-15 Impact factor: 10.338
Authors: Elon D Wallert; Elsmarieke van de Giessen; Remco J J Knol; Martijn Beudel; Rob M A de Bie; Jan Booij Journal: J Nucl Med Date: 2022-06 Impact factor: 11.082
Authors: Chris Vriend; Tim D van Balkom; Corné van Druningen; Martin Klein; Ysbrand D van der Werf; Henk W Berendse; Odile A van den Heuvel Journal: Neuroimage Clin Date: 2020-04-21 Impact factor: 4.881
Authors: Nicholas J Ashton; Shorena Janelidze; Ahmad Al Khleifat; Antoine Leuzy; Emma L van der Ende; Thomas K Karikari; Andrea L Benedet; Tharick A Pascoal; Alberto Lleó; Lucilla Parnetti; Daniela Galimberti; Laura Bonanni; Andrea Pilotto; Alessandro Padovani; Jan Lycke; Lenka Novakova; Markus Axelsson; Latha Velayudhan; Gil D Rabinovici; Bruce Miller; Carmine Pariante; Naghmeh Nikkheslat; Susan M Resnick; Madhav Thambisetty; Michael Schöll; Gorka Fernández-Eulate; Francisco J Gil-Bea; Adolfo López de Munain; Ammar Al-Chalabi; Pedro Rosa-Neto; Andre Strydom; Per Svenningsson; Erik Stomrud; Alexander Santillo; Dag Aarsland; John C van Swieten; Sebastian Palmqvist; Henrik Zetterberg; Kaj Blennow; Abdul Hye; Oskar Hansson Journal: Nat Commun Date: 2021-06-07 Impact factor: 14.919